Welcome to IDEaL – A Landmark Patient Registry Program
Coram Clinical Trials, an affiliate of Coram Specialty Infusion Services (An Apria Healthcare Company), is proud and excited to sponsor the Immunoglobulin, Diagnosis, Evaluation and key Learnings (IDEaL) Patient Registry Program.
Our goal is to provide a mechanism that allows for a better understanding of how immunoglobulin therapy is being used in a real-world clinical setting. The data gathered will help us gain a better understanding surrounding the therapeutic value of immunoglobulin therapy and subsequently improve practices, reduce medical costs, and ultimately enhance clinical outcomes for the patients we collectively serve.
The IDEaL Registry will serve as a platform for epidemiological analyses as well as the development of new therapeutic and treatment care strategies for the population of patients being treated with IVIg and SCIg in the home setting.
The IDEaL Patient Registry Program will fill an important niche between formal
clinical trials and real world clinical practice — providing an accurate view of the real treatment space.
